Print Page     Close Window     

SEC Filings

10-Q
SERES THERAPEUTICS, INC. filed this Form 10-Q on 05/09/2018
Entire Document
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

SERES THERAPEUTICS, INC.

 

 

 

Date: May 9, 2018

 

By:

 

/s/ Eric D. Shaff

 

 

 

 

Eric D. Shaff

 

 

 

 

Chief Operating and Financial Officer and Executive Vice President (principal financial and accounting officer)

 

 

62


© Seres Therapeutics. All Rights Reserved.